Clinical Trials Browser

Suspended × Interventional × Ovarian Neoplasms × Clear all

Ovarian Neoplasms

NCT04840589 2026-04-13

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Phase 1 Suspended

66 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms

NCT05000294 2026-02-18

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Phase 1/2 Suspended

29 enrolled

BreastEndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06666218 2026-01-14

Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)

Phase NA Suspended

60 enrolled

Gynecologic

Ovarian Neoplasms

NCT04711161 2024-01-23

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

Phase 1 Suspended

73 enrolled

Gynecologic

Ovarian Neoplasms

NCT04042116 2022-12-20

A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Phase 1/2 Suspended

227 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Endometrial Neoplasms

NCT03970382 2022-08-18

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Phase 1 Suspended

21 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT01218490 2019-05-16

CARACO

Phase 3 Suspended

450 enrolled

Gynecologic

Ovarian Neoplasms

NCT03393962 2018-07-31

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

Phase 1/2 Suspended

20 enrolled

Gynecologic

Ovarian Neoplasms

NCT02093871 2017-07-21

PISH-2

Phase 1 Suspended

20 enrolled

Gynecologic

Hyperthermia, Ovarian Neoplasms

NCT00753480 2008-11-07

A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 1 Suspended

56 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Helping Ovarian Cancer Patients Cope With Their Illness (HOPE)

First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.

A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

CARACO

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

PISH-2

A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer